RTI Surgical Wants to Become a $500 Million Spine Company—Can It Succeed?

article image

RTI Surgical is betting on a strategy of differentiation and scale to jumpstart its turnaround and catapult it into the top 10 spine companies in the next few years. Wall Street has yet to recognize its progress; this year and 2020 will be crucial for its success.

When Camille Farhat assumed the role of CEO and president of RTI Surgical Holdings Inc. in March 2017, the company was one of dozens of small-to-mid-sized spine companies competing for 25% of the total $10 billion market, while six large companies dominated the show.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: